Interactive acquisition of spatial information from images for multimedia applications

Dissertação para obtenção do Grau de Doutor em Informática

Video interaction using pen-based technology

Dissertação para obtenção do Grau de Doutor em Informática

A SDK improvement towards gesture support

Human-Computer Interaction have been one of the main focus of the technological community, specially the Natural User Interfaces (NUI) field of research as, since the launch of the Kinect Sensor, the goal to achieve fully natural interfaces just got a lot closer to reality. Taking advantage of this conditions the following research work proposes to compute the hand skeleton in order to recognize Sign Language Shapes. The proposed solution uses the Kinect Sensor to achieve a good segmentation and image analysis algorithms to extend the skeleton from the extraction of high-level features. In order to recognize complex hand shapes the current research work proposes the redefinition of the hand contour making it immutable to translation, rotation and scaling operations, and a set of tools to achieve a good recognition. The validation of the proposed solution extended the Kinects Software Development Kit to allow the developer to access the new set of inferred points and created a template-matching based platform that uses the contour to define the hand shape, this prototype was tested in a set of predefined conditions and showed to have a good success ration and has proven to be eligible for real-time scenarios.

Contribution to drug discovery and development for tauopathies using yeast as a model

This work aimed to contribute to drug discovery and development (DDD) for tauopathies, while expanding our knowledge on this group of neurodegenerative disorders, including Alzheimer’s disease (AD). Using yeast, a recognized model for neurodegeneration studies, useful models were produced for the study of tau interaction with beta-amyloid (Aβ), both AD hallmark proteins. The characterization of these models suggests that these proteins co-localize and that Aβ1-42, which is toxic to yeast, is involved in tau40 phosphorylation (Ser396/404) via the GSK-3β yeast orthologue, whereas tau seems to facilitate Aβ1-42 oligomerization. The mapping of tau’s interactome in yeast, achieved with a tau toxicity enhancer screen using the yeast deletion collection, provided a novel framework, composed of 31 genes, to identify new mechanisms associated with tau pathology, as well as to identify new drug targets or biomarkers. This genomic screen also allowed to select the yeast strain mir1Δ-tau40 for development of a new GPSD2TM drug discovery screening system. A library of unique 138 marine bacteria extracts, obtained from the Mid-Atlantic Ridge hydrothermal vents, was screened with mir1Δ-tau40. Three extracts were identified as suppressors of tau toxicity and constitute good starting points for DDD programs. mir1Δ strain was sensitive to tau toxicity, relating tau pathology with mitochondrial function. SLC25A3, the human homologue of MIR1, codes for the mitochondrial phosphate carrier protein (PiC). Resorting to iRNA, SLC25A3 expression was silenced in human neuroglioma cells, as a first step towards the engineering of a neural model for replicating the results obtained in yeast. This model is essential to understand the mechanisms of tau toxicity at the mitochondrial level and to validate PiC as a relevant drug target. The set of DDD tools here presented will foster the development of innovative and efficacious therapies, urgently needed to cope with tau-related disorders of high human and social-economic impact.